CNH Partners »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by CNH Partners

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by CNH Partners from 13F filings

Historical chart of CNH Partners investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by CNH Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by CNH Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $7.7M 8.2M 0.93

More positions owned by CNH Partners

Karuna Therapeutics Ord
Splunk Note 1.125% 6/1 (Principal)
ImmunoGen
Albertsons Cos Common Stock (ACI)
Cerevel Therapeutics Hldng I (CERE)
United States Steel Corporation (X)
Wayfair Note 3.250% 9/1 (Principal)
PNM Resources (PNM)
Etsy Note 0.250% 6/1 (Principal)
Amedisys (AMED)
Array Technologies Note 1.000%12/0 (Principal)
Gores Holdings Ix Class A Com (GHIX)
Hess (HES)
Lci Inds Note 1.125% 5/1 (Principal)
Pioneer Natural Resources (PXD)

View all positions for CNH Partners

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&g Investment Management
M&G
Calamos Advisors
Wolverine Asset Management
MacKay Shields
Citadel Advisors
Polar Securities
Millennium Management
Bank Of Montreal
Kohlberg Kravis Roberts & Co
D. E. Shaw & Co
Absolute Investment Advisers
Leucadia National Corporation
SSI Investment Management
CSS

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1